Skip to main content
EJNMMI Research
Fig. 3 | EJNMMI Research

Fig. 3

From: Influence of tumour size on the efficacy of targeted alpha therapy with 213Bi-[DOTA0,Tyr3]-octreotate

Fig. 3

Overview of mean tumour volumes ± standard deviation (SD) in mm3 per group after treatment of 213Bi-DOTATATE (2–4 MBq per injection) or unlabelled DOTATATE (control) in H69 and CA20948 tumour-bearing mice for three consecutive days. V 0 is the starting tumour volume. The dotted curves show the extrapolated growth curves of the tumours assuming 100 % survival of animals

Back to article page